Make Informed Investment Decisions with Affordable Access to Experts
With the recent delay on TLando's approval, a conversation about the market potential if approved.Ticker(s): LPCN, Clarus Therapeutics
A physician who is a high prescriber or testosterone products to patients and has followed the TLando story over the past few years.
Do you think TLando will be approved by the FDA in the coming weeks?Added By: joe_mccann
If TLando is approved, what % of your patients currently on testosterone replacement therapy would you switch to TLando?Added By: joe_mccann
Is there a group of patients who currently should be receiving testosterone therapy, but do not? Would TLando be a good option for them?Added By: joe_mccann
Do you think the TMax excursion issue was likely resolved in this filing?Added By: joe_mccann
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.